Portfolio Valuation: Life Sciences Investments
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
Pension Plan Needs Life Sciences Investment Portfolio Valuation
Fairness Opinion: Distressed M&A
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
Private Company Under Financial Distress Considering Transaction Alternatives
Inventory and Assessment: Healthcare System’s Oncology Data Assets
![RNA Subpage Banner](https://rnaadvisors.com/wp-content/uploads/2023/12/RNA_ReferralNetworkPartners-1024x320.png)
Comprehensive Inventory & Assessment of Integrated Health System’s Oncology Data
Emodo
Kevin Slawin, Rapha Capital PE
“As the founder of Rapha Capital, an investment advisory, as well as the founder and/or board member of multiple private-stage companies in the biotech and medtech arenas, I’ve worked with RNA in many capacities, including target identification, diligence and in transaction advisory capacities. They are my “go to” firm to help me with all of […]